Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
A. Blauvelt, E. Guttman-Yassky, A. Paller, E. Simpson +12 more
2022American Journal of Clinical Dermatology116 citations Open access
Semantic Scholar

